Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$920,517,565
+$206,472,638 QoQ
Shares Held
3,624,513
+24.1% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#70
of 4,676 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. JNJ ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,043,205 | $175,349,471 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $920,517,565 | 3,624,513 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $714,044,927 | 2,921,146 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $474,976,945 | 2,295,129 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $403,753,162 | 2,177,506 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $306,821,134 | 2,008,649 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $326,917,703 | 2,260,529 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $358,980,402 | 2,215,108 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $307,453,113 | 2,103,538 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $331,178,041 | 2,093,546 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $324,371,392 | 2,069,487 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $327,316,879 | 2,101,553 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $341,844,152 | 2,065,274 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $315,776,385 | 2,037,267 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $307,974,259 | 1,743,415 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $250,933,374 | 1,536,076 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $242,290,853 | 1,364,942 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $139,776,515 | 788,673 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $122,863,329 | 718,205 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $119,052,309 | 737,166 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $119,419,860 | 724,899 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $117,996,725 | 717,960 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||